Skip to content

The use of Virtual Reality (VR) pain psychology therapy to relieve chronic pain associated with cancer.

Virtual Reality pain psychology therapy as non-pharmacological analgesia for cancer-related chronic neuropathic pain.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12620000309987
Enrollment
40
Registered
2020-03-05
Start date
2020-03-06
Completion date
2020-06-06
Last updated
2020-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The study aims to evaluate a pain psychology therapy delivered by virtual reality to cancer patients with chronic pain. In addition, to confirm the feasibility and acceptability of VR use in a cancer population. Who is it for? You may be eligible for this study if you are 18 years or older with cancer. Study details Patients will be randomly allocated (50/50 chance) to either the intervention group or the control group. The intervention group will receive 3 x 30min sessions of VR-pain psychology therapy, as timed by a researcher. Each session will allow one module of the VR-pain therapy to be provided. The VR session will occur after the patient has seen their oncologist. The software program will incorporate three pain psychological modules: (1) Patient education on the nature and type of pain, and methods to control pain; (2) Teaching progressive muscle relaxation as a form of arousal reduction therapy; and (3) Guided pain visualisation technique to reduce pain catastrophising, reduce maladaptive response to pain, and improve functional outcomes Participants will be required to answer questionnaires about their quality of life and cancer symptoms at several time points, including, 1 month, 3 months, and 6 months after recruitment. It is hoped this trial will provide greater insight into the clinical effectiveness of the Virtual reality intervention on pain scores and can possibly offer cancer patients an alternative non-pharmacological analgesia.

Interventions

Patients in the intervention arm will receive 3x 30min sessions of VR-pain psychology therapy, as timed by a researcher. Each session will allow one module of the VR-pain therapy to be provided. Timepoints for follow-up is at 1 month, 3 months, and 6 months after recruitment. Each VR session will occur in separate clinical rooms located within the Cancer Centre Wellness unit at Liverpool Hospital to provide privacy for the patient, and to avoid disturbance to other patients concurrently onsite

Patients in the intervention arm will receive 3x 30min sessions of VR-pain psychology therapy, as timed by a researcher. Each session will allow one module of the VR-pain therapy to be provided. Timepoints for follow-up is at 1 month, 3 months, and 6 months after recruitment. Each VR session will occur in separate clinical rooms located within the Cancer Centre Wellness unit at Liverpool Hospital to provide privacy for the patient, and to avoid disturbance to other patients concurrently onsite for their outpatient visits. The VR session will occur after the patient has seen their oncologist. Our VR software program will incorporate three pain psychological modules: (1) Patient education on the nature and type of pain, and methods to control pain; (2) Teaching progressive muscle relaxation as a form of arousal reduction therapy; and (3) Guided pain visualisation technique to reduce pain catastrophising, reduce maladaptive response to pain, and improve functional outcomes These modules are selected by patients using their hand-motion controllers. Patients can advance, stop, or rewind the therapy. An electronic representation of a therapist (“avatar”) is projected through the VR goggles that will speak with the patient. Patients are required to be active participants, interacting with the avatar by choosing their therapy options in real time. The interaction between patient and VR-pain control therapy does not require external intervention from a psychologist. However, the view experienced by the patient is projected onto an external TV. This will be monitored by a researcher, who can intervene if necessary.

Sponsors

A/Prof Alwin Chuan
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adult (greater than or equal to 18yo) patients with cancer, and with the following characteristics: - Eastern Cooperative Oncology Group (ECOG) score 0-2 - Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) score greater than or equal to 12

Exclusion criteria

- Insufficient written English language proficiency to complete questionnaires. - Insufficient verbal English language proficiency to interact with the VR software avatar. - Psychological or psychiatric illness not stabilised with therapy and/or medications. - Uncertainty or unable to be followed up for subsequent six months after recruitment

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026